Analysis of long-term killing by armed T cells revealed a dose-dependent lysis of wildtype MM.1S tumors at increasing effector-target (E:T) ratios from 0.25:1 to 10:1, whereas tumor lysis was absent in CS1 knockout lines (Fig. 3C). The gene discussed is SLAMF7; the disease is neoplasm.